TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation

被引:11
作者
Ayash-Rashkovsky, M [1 ]
Bentwich, Z [1 ]
Borkow, G [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Agr, Hadassah Med Sch, Kaplan Med Ctr,Ruth Ben Ari Inst Clin Immunol, IL-76100 Rehovot, Israel
关键词
TLR9; chronic immune activation; PBMC; vaccines; CpG ODN;
D O I
10.1016/j.biocel.2005.05.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Millions of individuals in developing countries are infected with helminths and other chronic infectious diseases, such as HIV-1, which lead to persistent immune activation and unbalanced immune state. We have suggested that the capacity of chronically immune activated individuals to protect themselves, cope with infections, and mount protective immunity following vaccination, is highly impaired. Here we examined the expression of toll-like receptor 9 (TLR9), as an essential component in the recognition of immunostimulating bacterial CpG-DNA motifs, in different subsets of human peripheral blood mononuclear cells (PBMC) obtained from chronically immune activated and non-activated individuals. TLR9 expression was correlated to immune cell activation and was upregulated following phytohemagglutinin or anti-CD3 activation. PBMC obtained from chronically immune activated individuals had a different overall pattern of TLR9 expression, including reduced upregulation of this receptor following additional immune activation, and diminished responsiveness to CpG-DNA stimulation, in comparison to non-activated individuals. These differences may partly account for the reduced capacity of chronically immune activated individuals to mount effective immune responses and strengthen the notion that the host immune background should be considered in the design and trial of potential adjuvants and vaccines. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2380 / 2394
页数:15
相关论文
共 68 条
[61]   Immunostimulatory DNA sequences necessary for effective intradermal gene immunization [J].
Sato, Y ;
Roman, M ;
Tighe, H ;
Lee, D ;
Corr, M ;
Nguyen, MD ;
Silverman, GJ ;
Lotz, M ;
Carson, DA ;
Raz, E .
SCIENCE, 1996, 273 (5273) :352-354
[62]  
Stacey KJ, 1996, J IMMUNOL, V157, P2116
[63]   Toll-like receptors [J].
Takeda, K ;
Kaisho, T ;
Akira, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :335-376
[64]   Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs [J].
Verthelyi, D ;
Ishii, KJ ;
Gursel, M ;
Takeshita, F ;
Klinman, DM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2372-2377
[65]   Bacterial CpG DNA activates immune cells to signal infectious danger [J].
Wagner, H .
ADVANCES IN IMMUNOLOGY, VOL 73, 1999, 73 :329-368
[66]   Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity [J].
Wagner, H .
CURRENT OPINION IN MICROBIOLOGY, 2002, 5 (01) :62-69
[67]   LIPOFECTION OF SYNTHETIC OLIGODEOXYRIBONUCLEOTIDE HAVING A PALINDROMIC SEQUENCE OF AACGTT TO MURINE SPLENOCYTES ENHANCES INTERFERON-PRODUCTION AND NATURAL-KILLER ACTIVITY [J].
YAMAMOTO, T ;
YAMAMOTO, S ;
KATAOKA, T ;
TOKUNAGA, T .
MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (10) :831-836
[68]  
Yi AK, 1998, J IMMUNOL, V160, P5898